Antifolate

Cat.No. Product Name Information Product Use Citations Product Validations
S1210 Methotrexate Methotrexate, analog of folic acid, is a nonspecific inhibitor of the dihydrofolate reductase(DHFR) of bacteria and cancerous cells as well as normal cells. It forms an inactive ternary complex with DHFR and NADPH. Methotrexate (MTX) induces apoptosis.
J Clin Invest, 2025, e190215
Theranostics, 2025, 15(10):4526-4549
Antimicrob Agents Chemother, 2025, e0047125.
Verified customer review of Methotrexate
S5097 Methotrexate disodium Methotrexate sodium, an analog of folic acid, is a nonspecific inhibitor of the dihydrofolate reductase(DHFR) of bacteria and cancerous cells as well as normal cells. It forms an inactive ternary complex with DHFR and NADPH. Methotrexate (MTX) induces apoptosis.
Chin Med J (Engl), 2023, 10.1097/CM9.0000000000002816
Pharmaceutics, 2023, 15(2)576
Bioact Mater, 2022, 18:459-470
S1135 Pemetrexed Disodium (LY231514) Pemetrexed disodium is a novel antifolate and antimetabolite for TS, DHFR and GARFT with Ki of 1.3 nM, 7.2 nM and 65 nM in cell-free assays, respectively. Pemetrexed induces autophagy and apoptosis.
Nat Commun, 2025, 16(1):8932
Cell Death Dis, 2024, 15(8):555
Cell Commun Signal, 2024, 22(1):375
Verified customer review of Pemetrexed Disodium (LY231514)
S5264 L-5-Methyltetrahydrofolate calcium Calcium L-5-methyltetrahydrofolate (L-5-MTHF-Ca) is a synthetic derivative of folic acid, the predominant, naturally occurring form of folate.
E7308 Calcium N5-methyltetrahydrofolate Calcium N5-methyltetrahydrofolate(NSC173328) is the calcium salt of levomefolic acid, which has been proposed for treatment of cardiovascular disease and advanced cancers such as breast and colorectal cancers.
E7394 Methotrexate metabolite Methotrexate metabolite (DAMPA) is an active metabolite of Methotrexate. Methotrexate is a Folic acid (HY-16637) antagonist, widely used as an immunosuppressant. Methotrexate metabolite is an antimalarial agent that inhibits parasite growth under physiological folic acid conditions, with IC50 values of 446 nM and 812 nM against folic acid-sensitive strains and highly resistant strains, respectively. Methotrexate metabolite exhibits pharmacokinetic characteristics of rapid clearance and extensive metabolism, with a mean clearance rate of 1.9 l/kg/h and a mean terminal half-life of 51 minutes. Methotrexate metabolite is promising for research in the field of inflammation.
S7785 Pemetrexed Disodium Hydrate Pemetrexed Disodium Hydrate (LY-231514) is a novel antifolate and antimetabolite for TS, DHFR and GARFT with Ki of 1.3 nM, 7.2 nM and 65 nM, respectively. This compound stimulates autophagy and apoptosis.
iScience, 2024, 27(10):110862
Cell Rep, 2022, 38(9):110448
Front Pharmacol, 2022, 13:1032975
Verified customer review of Pemetrexed Disodium Hydrate
S5971 Pemetrexed Pemetrexed (LY231514) is a novel antifolate and antimetabolite for thymidylate synthase (TS), dihydrofolate reductase (DHFR) and glycinamide ribonucleotide formyltransferase (GARFT) with Ki of 1.3 nM, 7.2 nM and 65 nM in cell-free assays, respectively. This compound induces autophagy and apoptosis.
Nat Commun, 2025, 16(1):7853
Nat Commun, 2025, 16(1):8476
Sci Adv, 2025, 11(4):eadp4765
S1497 Pralatrexate Pralatrexate is an antifolate, and structurally a folate analog. Its IC50 is < 300 nM in some cell lines. This compound induces tumor cell apoptosis.
Cell Rep Med, 2025, S2666-3791(25)00102-8
Br J Haematol, 2024, 10.1111/bjh.19658
Discov Oncol, 2024, 15(1):709
Verified customer review of Pralatrexate
S1236 Leucovorin Calcium Pentahydrate (Folinic acid) Leucovorin (Folinic acid) Calcium Pentahydrate is a derivative of folic acid, which can be used to increase levels of folic acid under conditions favoring folic acid inhibition.Solutions are unstable and should be fresh-prepared.
J Exp Clin Cancer Res, 2025, 44(1):13
iScience, 2024, 27(10):110862
Cell Rep Med, 2023, 4(10):101200